Revolution Medicines, Inc. (RVMD)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
45.50+3.05 (+7.18%)
At close: 4:00PM EST
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Performance Outlook
| Previous Close | 42.45 |
| Open | 43.49 |
| Bid | 45.43 x 900 |
| Ask | 47.11 x 800 |
| Day's Range | 40.31 - 45.58 |
| 52 Week Range | 17.34 - 56.18 |
| Volume | 606,070 |
| Avg. Volume | 607,583 |
| Market Cap | 3.339B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
- Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover
- Analyst Report: Gilead Sciences, Inc.
© 2021 Verizon Media. All rights reserved.
